Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Jun 18, 2015 (11 years ago)

Disulfiram tablets

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Dissolution Specifications: During routine stability testing at the 12 month time point, one product lot was found to be out of specification for dissolution.

Cause type: Dissolution failure

The tablet or capsule did not dissolve within specification. Dissolution controls how much drug the body absorbs; a failure can change the effective dose. All dissolution failure recalls.

What was recalled

Disulfiram tablets, USP, 500 mg, 100-count bottles, Rx only, Manufactured for and by Qualitest Pharmaceuticals 130 Vintage Drive Huntsville, AL 35811. NDC 0603-3432-21.

Affected NDC 0603-3432-21

Compare with the code on your package — it is the most precise check available.

Drug: Disulfiram

Recalling firm
Qualitest Pharmaceuticals
NDC code
0603-3432-21
Origin
AL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D1151-2015 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Disulfiram recalls

See all
Class II · Moderate risk

Disulfiram active pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-634-2015
Class II · Moderate risk

DISULFIRAM Tablet

Labeling: Label Mixup; DISULFIRAM Tablet, 250 mg may be potentially mislabeled as PYRIDOXINE HCL, Tablet, 50 mg, NDC 00904052060, Pedigree: AD22865_22, EXP: 5/2/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-703-2014
Class III · Low risk

Disulfiram Tablets USP 250 mg

CGMP Deviation; cotton coil is missing in some packaged bottles

Terminated cGMP deviation Teva Pharmaceuticals USA, Inc. NDC 0093-5035-01 D-578-2013

Other recalls by Qualitest Pharmaceuticals

All 2015 recalls
Class III · Low risk

Allopurinol Tablets

Failed Tablet/Capsule Specifications; report of oversized and discolored tablets

Terminated Failed specification Qualitest Pharmaceuticals NDC 0603-2116-28 D-1405-2015
Class III · Low risk

Promethazine Vc With Codeine Syrup

Failed Impurities/Degradation Specifications: A stability lot was out of specification for a known impurity at the 8 month Controlled Room Temperature stability time-point.

Terminated Impurity / degradation Qualitest Pharmaceuticals NDC 0603-1588-54 D00432-2015